Exelixis Access Services^® (EASE)

Access. Assistance. Along the journey.

EASE was established by Exelixis, Inc. to provide a variety of support to help patients get started on CABOMETYX^® (cabozantinib) as soon as possible.

EASE offers regionally dedicated Case Managers as a single point of contact.

• Offers prompt support with payer coverage, financial assistance, and treatment coordination
• Can provide the status of a patients’ access journey
• Provides proactive follow-up

EASE Programs and Services

• 15-Day Free Trial Program: Provides free drug to help patients start treatment quickly*^†
• CABOMETYX Quick Start Program: Provides free drug to eligible patients who experience a payer decision delay of 5 days or more*^†
• EASE Co-pay Program: Eligible commercially insured patients pay $0 per month for a maximum benefit of $25,000 per year^†
• EASE Dose Exchange Program: Provides a free 15-tablet supply in the lower dose to help patients who require a dose reduction^†
• EASE Patient Assistance Program (PAP): Eligible patients who cannot afford their drug costs may receive CABOMETYX free of charge^†
• Patient Care Kit: Provides tools and resources to patients on CABOMETYX^†

*Limited to on-label indications. Additional restrictions and eligibility rules apply.
†Additional restrictions and eligibility rules apply.

Contact EASE for More Information and to Enroll
CALL: 1-844-900-EASE (1-844-900-3273) Monday to Friday 8:00 am to 8:00 pm (ET)
VISIT: www.EASE.US

Please see the full Prescribing Information for CABOMETYX.